Nachrichten zur Amneal Pharmaceuticals Inc. Aktie

Amneal Pharmaceuticals, Inc. (AMRX) Q2 2024 Earnings Call Transcript

…

Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 14.29% and 6.75%, respectively, for the quarter ended June 2024. Do the…

Amneal Pharmaceuticals: Maintaining Momentum Is Key To Success

…

Global Muscle Relaxant Drugs Market Size To Worth USD 5.91 Billion By 2033 | CAGR Of 4.24%

The Global Muscle Relaxant Drugs Market Size was Valued at USD 3.90 Billion in 2023 and the Worldwide Muscle Relaxant…

Global Parkinson’s Disease Treatment Market Size To Worth USD 9.14 Billion By 2033 | CAGR Of 6.41%

The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…

Canadian Pharma Stocks: 5 Biggest Companies in 2024

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…

Amneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation

…

Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript

…

Drugmaker Amneal agrees to $270 million U.S. opioid settlement

Amneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to resolve claims it…

Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 55.56% and 5.80%, respectively, for the quarter ended March 2024. Do the…

Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0%

The Global Testosterone Replacement Therapy Market Size was Valued at USD 1.98 Billion in 2023 and the Worldwide Testosterone Replacement…

Bausch (BHC) Starts Litigation Against Amneal for Xifaxan

Bausch (BHC) initiates litigation against Amneal Pharmaceuticals and its subsidiaries over a generic version of its lead drug Xifaxan.…

Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82%

The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…

Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023 By Investing.com

Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023…

Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript

…

Amneal Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation

…

Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 100% and 2.17%, respectively, for the quarter ended December 2023. Do the…

Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203

MONTREAL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical…

AMNEAL INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) and Encourages Investors with Losses to Contact the Firm

PHILADELPHIA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Amneal Pharmaceuticals, Inc.…

Amneal Pharmaceuticals: By Most Measures, A Fundamentally Undervalued Company

…

Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript

…

Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

JPMorgan Overhauls Loan for Amneal Pharmaceuticals After Investor Backlash

A leveraged loan deal from Amneal Pharmaceuticals LLC has been revamped after facing investor pushback.…

Form 10-Q Amneal Pharmaceuticals, For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amneal Pharma Shares Rise 24% After 2Q Revenue Beat, Higher Guidance

Amneal Pharma Shares Rise 24% After 2Q Revenue Beat, Higher Guidance...…

Amneal (AMRX) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Amneal (AMRX) give insight into how the company performed in the quarter ended June 2023, but…

Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 90% and 6.50%, respectively, for the quarter ended June 2023. Do the…

Form 8-K Amneal Pharmaceuticals, For: Aug 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.09, revenue of $599M beats by $33.89M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amneal Pharmaceuticals Q2 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?

Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday

The company received a complete response letter from the FDA regarding a Parkinsons disease generic therapy....…

MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall, Wednesday, 7/5/2023

Stocks that traded heavily or had substantial price changes Wednesday: MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall...…

Amneal Pharmaceuticals Shares Slide 16% After FDA Rejects Parkinsons Drug

Amneal Pharmaceuticals Shares Slide 16% After FDA Rejects Parkinson's Drug...…

Amneal Pharmaceuticals: FDA Requests Additional Information on IPX203 Ingredient

Amneal Pharmaceuticals: FDA Requests Additional Information on IPX203 Ingredient...…

Amneal Pharma Receives Approvals for Generic Drug Applications

Amneal Pharma Receives Approvals for Generic Drug Applications...…

Amneal granted FDA nod for chemotherapy injection

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amneal Pharmaceuticals Gets FDA Approval for Injectable Tumor Treatment

Amneal Pharmaceuticals Gets FDA Approval for Injectable Tumor Treatment...…

Form 8-K Amneal Pharmaceuticals, For: May 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Amneal Pharmaceuticals, For: May 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amneal Pharmaceuticals Non-GAAP EPS of $0.12 beats by $0.02, revenue of $558M beats by $15.82M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for

Amneal (AMRX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Amneal Pharmaceuticals Shares Rise on Strong 1Q Revenue Projection

Amneal Pharmaceuticals Shares Rise on Strong 1Q Revenue Projection...…

Amneal Pharmaceuticals’ stock soars 14% premarket after company offers upbeat Q1 guidance

Amneal Pharmaceuticals Inc.’s stock AMRX soared 14% in premarket trade Monday, after the generics and specialty pharmaceuticals company offered first-quarter…

Form 8-K Amneal Pharmaceuticals, For: Apr 17

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amneal pops 3% after early look at Q1 results, re-affirms FY23 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Expert Ratings for Amneal Pharmaceuticals

Latest Ratings for AMRX DateFirmActionFromTo Mar 2021Goldman SachsUpgradesSellBuy Dec 2020GuggenheimUpgradesNeutralBuy Nov 2020SVB LeerinkMaintainsMarket Perform View…

Amneal Pharmaceuticals stock price target cut to $4 from $5 at Truist

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Gene therapy developer AskBio appoints ex Amneal commercial chief as CEO

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K Amneal Pharmaceuticals, For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…